scispace - formally typeset
G

Geltrude Mingrone

Researcher at King's College London

Publications -  454
Citations -  24376

Geltrude Mingrone is an academic researcher from King's College London. The author has contributed to research in topics: Insulin resistance & Insulin. The author has an hindex of 61, co-authored 426 publications receiving 19664 citations. Previous affiliations of Geltrude Mingrone include The Catholic University of America & University of Ferrara.

Papers
More filters
Journal ArticleDOI

Oxidation of [1,12-14C]dodecanedioic acid by rat pancreatic islets.

TL;DR: Findings support the view that the insulinotropic action of dodecanedioic acid, and presumably other aliphatic dioic acids, is causally linked to their capacity to act as nutrients in pancreatic islet cells.
Journal ArticleDOI

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

TL;DR: The number of patients with Type 2 diabetes (T2D) worldwide is expected to increase from 463 million in 2019 to 700 million in 2045, with a prevalence of more than 10% in Europe as discussed by the authors.
Journal Article

Enteral diet in Crohn's disease. Nutritional and therapeutic implications in patient's management.

TL;DR: This work presents some of the possible mechanisms of efficacy of enteral feeding and some rules to attempt to treat patients with IBD, especially those with Crohn's disease.
Journal Article

Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis

Abstract: The pharmacokinetics of netilmicin after i.v. administration were studied in 10 adult hemodialyzed patients during and after a dialysis session. The mean interdialysis half-life was 49.6 h, whereas during dialysis this value was reduced to 5.02 h. The mean volume of distribution of netilmicin was about 20% of the total body weight. The dialyzer clearance of netilmicin, measured at 60 and 150 min after the beginning of the session, was about 50 ml/min; this means that 60-65% of the drug may be lost during the 4.5 h standard dialysis. The total body clearance of netilmicin was similar to the dialyzer clearance values, suggesting that the drug is eliminated almost entirely by hemodialysis and that its renal elimination in our patients is negligible. In conclusion, in uremic hemodialyzed patients netilmicin behaves like other aminoglycosides.

Free fatty acids stimulate mucin hypersecretion by rabbit gall-bladder epithelium in vitro

TL;DR: This paper showed that free fatty acids, which appear in high amounts when bile lecithins are hydrolysed by phospholipase, play an active role in the gall-stone formation.